Program death inhibitors in classical Hodgkin’s lymphoma: a comprehensive review Reyad Dada Review Article 10 January 2018 Pages: 555 - 561
Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents Shunan WangXingtong WangOu Bai Review Article 17 February 2018 Pages: 563 - 572
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG Gianni B. ScappaticciBernard L. MariniAnthony J. Perissinotti Original Article 29 December 2017 Pages: 573 - 584
Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL) Sepideh ShahkaramiRoya MehrasaSeyed H. Ghaffari Original Article 01 February 2018 Pages: 585 - 595
Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience) Raihane Ben LakhalHela GhediraBalkis Meddeb Original Article 06 January 2018 Pages: 597 - 604
Phosphatidylserine-exposing blood and endothelial cells contribute to the hypercoagulable state in essential thrombocythemia patients Dongxia TongMuxin YuJialan Shi Original Article 13 January 2018 Pages: 605 - 616
Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies Jean-Jacques KiladjianPaola GuglielmelliSrdan Verstovsek Original Article 02 February 2018 Pages: 617 - 627
A novel heterozygous ITGB3 p.T720del inducing spontaneous activation of integrin αIIbβ3 in autosomal dominant macrothrombocytopenia with aggregation dysfunction Naohiro MiyashitaMasahiro OnozawaTakanori Teshima Original Article 29 January 2018 Pages: 629 - 640
Diminished expression of β2-GPI is associated with a reduced ability to mitigate complement activation in anti-GPIIb/IIIa-mediated immune thrombocytopenia Xiaolu ZhuJiamin ZhangXiaohui Zhang Original Article 29 December 2017 Pages: 641 - 654
Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia Emi TogasakiNaomi ShimizuChiaki Nakaseko Original Article 13 January 2018 Pages: 655 - 662
Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas Francesco GaudioRoberto TammaGiorgina Specchia Original Article 23 January 2018 Pages: 663 - 668
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database Andrea JanikovaZbynek BortlicekMarek Trneny Original Article 09 January 2018 Pages: 669 - 678
Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with β-thalassemia major Maryam Sadat MirlohiHamid YaghootiSamaneh Olapour Original Article 09 January 2018 Pages: 679 - 684
Influence of genetic polymorphisms of IL23R, STAT3, IL12B, and STAT4 on the risk of aplastic anemia and the effect of immunosuppressive therapy Li ZhaoHuanling ZhuLi Qin Original Article 12 January 2018 Pages: 685 - 695
Total body irradiation tremendously impair the proliferation, differentiation and chromosomal integrity of bone marrow-derived mesenchymal stromal stem cells Wen-Jyi LoChiao-Lin LinSu-Peng Yeh Original Article 18 January 2018 Pages: 697 - 707
Further classification of neutrophil non-muscle myosin heavy chain-IIA localization for efficient genetic diagnosis of MYH9 disorders Jihong HaoAkiko KadaShinji Kunishima Letter to the Editor 04 December 2017 Pages: 709 - 711
Is there a role for the international prognostic index in follicular lymphoma? Marc SorigueSantiago MercadalJuan-Manuel Sancho Letter to the Editor 13 December 2017 Pages: 713 - 715
Primary effusion lymphoma-like lymphoma with a T cell phenotype Takaomi KobayashiDaisuke MoriEijo Matsuishi Letter to the Editor 04 December 2017 Pages: 717 - 718
The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients Hugo J. A. AdamsThomas C. Kwee Letter to the Editor 08 December 2017 Pages: 719 - 720
T cell large granular lymphocytic leukemia, a rare form of post lung transplant lymphoproliferative disorder Omer A. M. SaeedHarold O. LongeJiehao Zhou Letter to the Editor 08 January 2018 Pages: 721 - 722
MRD-negative complete remission in relapsed refractory hairy cell leukemia with bendamustine and obinutuzumab Navid SadeghiHsiao C. Li Letter to the Editor 28 December 2017 Pages: 723 - 724
Prognostic factors of ALK-negative anaplastic large-cell lymphoma: a single-institution experience Raoudha DoghriLinda Bel HadjKacemKarima Mrad Letter to the Editor 23 January 2018 Pages: 725 - 726
Efficacy of antithymocyte globulin as first-line treatment for aplastic anemia—a single-center experience I. A. van ZeventerJ. W. G. M. SchreursM. R. de Groot Letter to the Editor 16 December 2017 Pages: 727 - 730
Low-virulent Babesia venatorum infection masquerading as hemophagocytic syndrome Jonas BläckbergVladimir Lj LazarevicKristina E. M. Persson Letter to the Editor 29 December 2017 Pages: 731 - 733
Non-severe form of severe fever with thrombocytopenia syndrome (SFTS) Yutaka ShimazuYasuhiro SaitoMasaharu Nohgawa Letter to the Editor 03 January 2018 Pages: 735 - 736
Progression to polythythemia vera from familial thrombocytosis with germline JAK2 R867Q mutation Koichiro MaieYasuhisa YokoyamaShigeru Chiba Letter to the Editor 24 January 2018 Pages: 737 - 739
Immune thrombocytopenia induced by vonoprazan fumarate: a single center retrospective study Naruko SuzukiJunji HiragaYoshitoyo Kagami Letter to the Editor 16 December 2017 Pages: 741 - 742
Atrial fibrillation and MPNs Alberto Alvarez-Larrán Letter to the Editor 15 January 2018 Pages: 743 - 743
